2 chapters across the catalog
The discussion examines the overrepresentation of Black women and gay men in modern pharmaceutical commercials for PrEP. Questions are raised about why these groups are targeted in advertising if the medical community considers the crisis "solved." The hosts debate whether modern HIV symptoms are a result of the virus or the treatments provided.
Despite medical advancements, a survey indicates that one-third of HIV-negative millennials still avoid physical contact with HIV-positive individuals. The discussion shifts to the high cost of Truvada, noting that a month's supply can cost $2,000 without insurance. The hosts question why life-saving preventative drugs are not provided for free if the goal is to "flatten the curve."
